Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Induction in Morbid Obesity
NCT05856617Phase 4Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Oct 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam, sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05856617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05856617.